CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07340853 · SUSPENDED
Trial details
- NCT number
- NCT07340853
- Sponsor
- Thomas Martin, MD
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2028-05-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.